Rhythm Pharmaceuticals (RYTM) Reports In-Line Q4 EPS, provides guidance
Go back to Rhythm Pharmaceuticals (RYTM) Reports In-Line Q4 EPS, provides guidance| (NASDAQ: RYTM) | Delayed: 88.38 +0.72 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.66 | 52 Week High | $ | |||
| Open | $87.65 | 52 Week Low | $ | |||
| Day High | $90.16 | P/E | N/A | |||
| Day Low | $87.65 | EPS | $ | |||
| Volume | 554,412 | |||||

